ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Incidence of Rejection and Antibody Formation after Immunosuppression Reduction in Patients with Biopsy Proven Polyomavirus Nephropathy

M. Kleman, R. Detwiler, H. Singh, V. Nickeleit.

University of North Carolina, Chapel Hill, NC.

Meeting: 2018 American Transplant Congress

Abstract number: C199

Keywords: Immunosuppression, Infection, Polyma virus, Rejection

Session Information

Date: Monday, June 4, 2018

Session Name: Poster Session C: Kidney: Polyoma

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Related Abstracts
  • Neutrophil-to-Lymphocyte Ratio as a Predictor of Polyomavirus BK Nephropathy in Kidney Transplant Patients.
  • The Risk Factors of Acute Rejection in Patients with BK Nephropathy after the Reduction of Immunosuppression

The purpose of this study is to determine the incidence of rejection and donor specific antibody (DSA) formation after immunosuppression reduction in patients with biopsy proven polyomavirus nephropathy (PVN). We identified 57 out of the 617 patients (9.2%) who received a kidney transplant at our center between 1/1/2009 and 4/28/2017 who were given a histologic diagnosis of polyomavirus nephropathy between 4/29/2009 and 4/28/2017. Electronic medical records were reviewed to find occurrence of rejection episodes and donor antibody formation prior to and following the diagnosis of PVN, and methods of immunosuppression reduction or other therapies. Graft function and survival were ascertained by comparing the estimated glomerular filtration rate (eGFR) with the Modification of Diet in Renal Disease Study equation at the time of diagnosis to the eGFR at a mean follow up of 20.2 months. Nephrologists approached treatment differently, however anti-metabolites were stopped or dose-reduced and tacrolimus trough level goals were decreased to 4-7 ng/mL in all those reviewed. Forty-eight of the 57 patients were treated with leflunomide and three received intravenous immune globulin for PVN. Six of the 57 patients (10.5%) had an episode of rejection preceding PVN diagnosis (5 had acute cellular rejection [ACR], 1 had acute antibody mediated rejection [AMR]) and 13 patients (22.8%) had an episode of rejection after the diagnosis of PVN (11 had ACR, 1 had AMR, 1 had mixed ACR and AMR). In those who developed rejection after PVN, it occurred an average of 10.1 months after the diagnosis. Eleven patients (19.3%) developed a DSA (5 had Class 1 antigens and 6 had Class 2 antigens) and a DSA was found after PVN diagnosis in 7 (11.4%) patients. Among the patients who developed DSAs, two had a history of ACR prior to DSA discovery. Average eGFR at the time of PVN diagnosis was 43.7 mL/min and 40.6 mL/min at follow up. Five patients developed end stage renal disease requiring dialysis: 1 patient due to recurrent glomerulonephritis, 1 patient due to rejection, and 2 patients due to PVN. Four patients died (2 had death with functioning graft). Our findings suggest that reduction in immunosuppression after diagnosis of PVN is associated with a possible increase in the incidence of rejection and DSA development. Fortunately, this does not seem to have an immediate impact on graft survival, but there does appear to be an association with reduced graft function.

CITATION INFORMATION: Kleman M., Detwiler R., Singh H., Nickeleit V. Incidence of Rejection and Antibody Formation after Immunosuppression Reduction in Patients with Biopsy Proven Polyomavirus Nephropathy Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kleman M, Detwiler R, Singh H, Nickeleit V. Incidence of Rejection and Antibody Formation after Immunosuppression Reduction in Patients with Biopsy Proven Polyomavirus Nephropathy [abstract]. https://atcmeetingabstracts.com/abstract/incidence-of-rejection-and-antibody-formation-after-immunosuppression-reduction-in-patients-with-biopsy-proven-polyomavirus-nephropathy/. Accessed December 5, 2019.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2019 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

wiley-new-logo

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.